Full Transcript: Exagen Q2 2026 Earnings Call
On Tuesday, Exagen (NASDAQ: XGN ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit View the webcast at Summary Exagen Inc. reported record quarterly revenue of $19.9 million,